Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Sitagliptin intermediate compounds, preparation methods and uses thereof
Apparatus and method for information display of portable device
Fluorescent proteins
Washing machine
Systems and methods for automated institutional processing of payments
Disk drive to enable defect margining
Software execution management apparatus, method, and computer-readable medium thereof
  Randomly Featured Patents
Magnetic/centrifugal-fluid seal
Image display apparatus and optical system
Semiconductor memory device
Methods of treating allergic reactions using hydrated forms of antihistaminic piperidine derivatives
Sorbent-based gas storage and delivery system
Methods of forming metal foil ply replacement in composite structures
Plasma-like substance
Tow claims system for secondary tow and salvage management
Canine cleanroom suit
Process for the preparation of an aromatic carboxylic acid